-
Something wrong with this record ?
Iodinated Choline Transport-Targeted Tracers
P. Švec, Z. Nový, J. Kučka, M. Petřík, O. Sedláček, M. Kuchař, B. Lišková, M. Medvedíková, K. Kolouchová, O. Groborz, L. Loukotová, RŁ. Konefał, M. Hajdúch, M. Hrubý
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Apoptosis MeSH
- Choline analogs & derivatives pharmacokinetics MeSH
- Humans MeSH
- Mice, SCID MeSH
- Mice MeSH
- Tumor Cells, Cultured MeSH
- Prostatic Neoplasms diagnostic imaging metabolism pathology MeSH
- Positron-Emission Tomography MeSH
- Cell Proliferation MeSH
- Radioactive Tracers * MeSH
- Radiopharmaceuticals pharmacokinetics MeSH
- Fluorine Radioisotopes pharmacokinetics MeSH
- Iodine Radioisotopes pharmacokinetics MeSH
- Tissue Distribution MeSH
- Xenograft Model Antitumor Assays MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
We present a novel series of radioiodinated tracers and potential theranostics for diseases accompanied by pathological function of proteins involved in choline transport. Unlike choline analogues labeled with 11C or 18F that are currently used in the clinic, the iodinated compounds described herein are applicable in positron emission tomography, single-photon emission computed tomography, and potentially in therapy, depending on the iodine isotope selection. Moreover, favorable half-lives of iodine isotopes result in much less challenging synthesis by isotope exchange reaction. Six of the described compounds were nanomolar ligands, and the best compound possessed an affinity 100-fold greater than that of choline. Biodistribution data of 125I-labeled ligands in human prostate carcinoma bearing (PC-3) mice revealed two compounds with a biodistribution profile superior to that of [18F]fluorocholine.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011702
- 003
- CZ-PrNML
- 005
- 20211207151954.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.0c01710 $2 doi
- 035 __
- $a (PubMed)33271015
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Švec, Pavel $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Hlavova 8, Prague 2 128 43, Czech Republic
- 245 10
- $a Iodinated Choline Transport-Targeted Tracers / $c P. Švec, Z. Nový, J. Kučka, M. Petřík, O. Sedláček, M. Kuchař, B. Lišková, M. Medvedíková, K. Kolouchová, O. Groborz, L. Loukotová, RŁ. Konefał, M. Hajdúch, M. Hrubý
- 520 9_
- $a We present a novel series of radioiodinated tracers and potential theranostics for diseases accompanied by pathological function of proteins involved in choline transport. Unlike choline analogues labeled with 11C or 18F that are currently used in the clinic, the iodinated compounds described herein are applicable in positron emission tomography, single-photon emission computed tomography, and potentially in therapy, depending on the iodine isotope selection. Moreover, favorable half-lives of iodine isotopes result in much less challenging synthesis by isotope exchange reaction. Six of the described compounds were nanomolar ligands, and the best compound possessed an affinity 100-fold greater than that of choline. Biodistribution data of 125I-labeled ligands in human prostate carcinoma bearing (PC-3) mice revealed two compounds with a biodistribution profile superior to that of [18F]fluorocholine.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a cholin $x analogy a deriváty $x farmakokinetika $7 D002794
- 650 _2
- $a radioizotopy fluoru $x farmakokinetika $7 D005462
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a radioizotopy jodu $x farmakokinetika $7 D007457
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši SCID $7 D016513
- 650 _2
- $a pozitronová emisní tomografie $7 D049268
- 650 _2
- $a nádory prostaty $x diagnostické zobrazování $x metabolismus $x patologie $7 D011471
- 650 12
- $a radioaktivní indikátory $7 D011849
- 650 _2
- $a radiofarmaka $x farmakokinetika $7 D019275
- 650 _2
- $a tkáňová distribuce $7 D014018
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nový, Zbyněk $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, Olomouc 779 00, Czech Republic
- 700 1_
- $a Kučka, Jan $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 700 1_
- $a Petřík, Miloš $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, Olomouc 779 00, Czech Republic
- 700 1_
- $a Sedláček, Ondřej $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 700 1_
- $a Kuchař, Martin $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology, Technická 1905/5, Prague 160 00, Czech Republic
- 700 1_
- $a Lišková, Barbora $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, Olomouc 779 00, Czech Republic $7 xx0267204
- 700 1_
- $a Medvedíková, Martina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, Olomouc 779 00, Czech Republic
- 700 1_
- $a Kolouchová, Kristýna $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 700 1_
- $a Groborz, Ondřej $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 700 1_
- $a Loukotová, Lenka $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 700 1_
- $a Konefał, Rafał Ł $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, Olomouc 779 00, Czech Republic
- 700 1_
- $a Hrubý, Martin $u Institute of Macromolecular Chemistry, CAS, Heyrovského sq. 2, Prague 6 162 06, Czech Republic
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 63, č. 24 (2020), s. 15960-15978
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33271015 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20211207151952 $b ABA008
- 999 __
- $a ok $b bmc $g 1650159 $s 1132081
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 63 $c 24 $d 15960-15978 $e 20201203 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20210420